Evidence map›Paper›PMID 39875508›Full record

ArticleScientific reports2025

Spatial accuracy of dose delivery significantly impacts the planning target volume margin in linear accelerator-based intracranial stereotactic radiosurgery.

Yuta Takahashi, Riki Oshika, Rie Tachibana, Katsuyuki Shirai, Hiroshi Asakura, Masayoshi Miyazaki, Tomohiro Sagawa, Shinichi Takahashi, Tsunekazu Kuwae, Hironori Kojima and 18 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Yuta TakahashiDivision of Radiation Medical Physics, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Riki OshikaRadiation Safety and Quality Assurance division, National Cancer Center Hospital East, Chiba, 277-8577, Japan.
Rie TachibanaTriangle Products Co. Ltd, Chiba, Japan.
Katsuyuki ShiraiDepartment of Radiation Oncology, Jichi Medical University Hospital, Tochigi, Japan.
Hiroshi AsakuraRadiation Oncology Center, Dokkyo Medical University Hospital, Tochigi, Japan.
Masayoshi MiyazakiDepartment of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
Tomohiro SagawaDepartment of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
Shinichi TakahashiDivision of Radiation Technology, Hospital East, National Cancer Center, Chiba, Japan.
Tsunekazu KuwaeDivision of Radiology, Yuuai Medical Center, Okinawa, Japan.
Hironori KojimaDepartment of Radiology, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.
Shiro NishiyamaDepartment of Radiotechnology, Saiseikai Kawaguchi General Hospital, Saitama, Japan.
Hikaru NemotoDepartment of Radiology, University of Yamanashi, Yamanashi, Japan.
Yoshitomo IshiharaDepartment of Radiation Oncology, Division of Medical Physics, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
Mariko UmedaDepartment of Radiation Oncology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Kotaro KijimaDepartment of Radiology, NHO Saitama Hospital, Saitama, Japan.
Daisuke KobayashiDepartment of Radiology, University of Tsukuba Hospital, Ibaraki, Japan.
Keiji SuzukiDepartment of Radiology, University of Tsukuba Hospital, Ibaraki, Japan.
Yuki NozawaDepartment of Radiology, The University of Tokyo Hospital, Tokyo, Japan.
Kento HoshidaDepartment of Radiology, Kurume University Hospital, Fukuoka, Japan.
Tomoki KitagawaDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
Hiromitsu EndoDepartment of Radiation Physics and Technology, Southern TOHOKU General Hospital, Fukushima, Japan.
Yuki MatsunagaDepartment of Radiology, Fukuoka Tokushukai Hospital, Fukuoka, Japan.
Hiroya ItagakiDepartment of Radiology, Niigata City General Hospital, Niigata, Japan.
Mayumi IshidaDivision of Radiology, JCHO Osaka Hospital, Osaka, Japan.
Shigeru KanaharaCentral Radiology Division, Kawasaki Medical School General Medical Center, Okayama, Japan.
Ryo HoritaCentral Radiology Division, Nagoya City University East Medical Center, Aichi, Japan.
Daisuke HoriDepartment of Radiology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.
Hidenobu TachibanaRadiation Safety and Quality Assurance division, National Cancer Center Hospital East, Chiba, 277-8577, Japan. htachiba@east.ncc.go.jp.

Funding

Triangle Products Co.Ltd. C2019-134
6 · The paper itself

Abstract

The impact of three-dimensional (3D) dose delivery accuracy of C-arm linacs on the planning target volume (PTV) margin was evaluated for non-coplanar intracranial stereotactic radiosurgery (SRS). A multi-institutional 3D starshot test using beams from seven directions was conducted at 22 clinics using Varian and Elekta linacs with X-ray CT-based polymer gel dosimeters. Variability in dose delivery accuracy was observed, with the distance between the imaging isocenter and each beam exceeding 1 mm at one institution for Varian and nine institutions for Elekta. The calculated PTV margins for Varian and Elekta linacs that could cover the gross tumor volume with 95% probability at 95% of the institutions were 2.3 and 3.5 mm, respectively, in the superior-inferior direction. However, with multifactorial system management (i.e., high-accuracy 3D dose delivery with rigorous linac quality assurance, strict patient immobilization, and high intra-fractional positioning accuracy), these margins could be reduced to 1.0 mm and 1.5 mm, respectively. The findings indicate significant millimeter-level variability in 3D dose delivery accuracy among linacs installed in clinical settings. Thus, maximizing a linac's 3D dose delivery accuracy is essential to achieve the required PTV margin in intracranial SRS.

Indexed as

Brain NeoplasmsParticle AcceleratorsRadiosurgeryRadiotherapy Planning, Computer-AssistedHumansRadiotherapy DosageTomography, X-Ray ComputedGel dosimeterLinacMargin sizeMulti-institutionSRSThree-dimensional dose delivery accuracy

Identifiers

PMID39875508
PMCPMC11775166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.